The American Heart Health Association has identified a new syndrome that links heart disease, metabolic disorders, and kidney disease. The advisory published by them has set out profound links between the three diseases and suggests prevention and risk management courses. Better education about this syndrome can help people with early detection and avoid life-threatening risks.
The Association’s flagship journal Circulation points to the overlapping aspects of Type 2 Diabetes and obesity with Kidney diseases. According to the advisory, it is believed that individuals who are suffering from cardiovascular disease have CKM syndrome.
The new approach to tackle this syndrome includes stages, screening, a collaborative care approach, and a risk calculator. In this blog, we are going to understand the new advisory completely.
Screening Of CKM Syndrome
The advisory has a new perspective of looking at heart disease. 1 in 3 adults suffer from heart disease in the US, and that is why screening for this syndrome is advised at an early age of 3.
The American Academy of Pediatricians aligns with the motive and is to monitor the annual weight, blood pressure, and mental and behavioral health of children and youth. Detecting CKM changes from an early age can help social and structural barriers to care and stop the progress of the syndrome.
Stages Of CKM Syndrome
The advisory suggests categorizing the symptoms of CKM syndrome into 4 stages, where stage 0 has no risk factors and Stage 4 contains guidance on how to treat the syndrome.
- Stage 0
The main purpose of this motive is to create awareness among people about healthy eating habits, physical activity, getting sufficient sleep, and checking up on your body. With the advisory’s guidance adults are recommended to avoid nicotine, and keep check on their body mass index.
- Stage 1
This stage is for individuals who show signs of excess body fat or uneven distribution of body fat. It is advised to lose 5% of weight with physical activity and treatment for glucose intolerance when needed.
- Stage 2
This stage categorizes individuals who show signs of metabolic risk factors and kidney diseases. Medications like SGLT2 inhibitors to protect kidney function, and Glucagon-like peptide 1 for Type 2 diabetes, are recommended. This also includes a regular screening of blood pressure, triglycerides, cholesterol, blood sugar, and kidney function for these individuals.
- Stage 3
This stage is for people who do not show any signs of metabolic risk factors or kidney disease but still have symptoms of early cardiovascular disease. These individuals are treated with medications to lower their cholesterol and undergo CAC screening. The goal is to prevent heart failure symptoms and regress CKM syndrome.
- Stage 4
This stage is divided into sub-parts 4a and 4b. 4a includes treatment for individuals without kidney failure and 4b is for individuals with it. Proper treatment and medications are advised while keeping CKM syndrome symptoms in mind.
The advisory proposes to update the risk calculator established in 2013, which only considers the age range of 40-75. Since CKM syndrome can be found in younger age groups, the risk calculator should be able to assess the risk from the age of 10-30. This will help to prevent the syndrome from progressing.
With the collaborative care approach, the advisory provides guidelines to assess the health of individuals from a young age. Preventing the syndrome is a solution to avoid heart, kidney, or metabolic diseases.
Apart from this, there are areas where people need to be educated about the structure of this advisory. People with complete information will be able to make the right decisions at the right time.